Provectus Biopharmaceuticals, Inc. Stock
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0680 USD | -1.83% |
|
-1.30% | +21.82% |
| Market Cap | 28.6M 25.02M 23.07M 21.31M 40.44M 2.73B 41.12M 276M 108M 1.34B 107M 105M 4.62B | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 31.33M 27.4M 25.27M 23.34M 44.29M 2.99B 45.04M 302M 119M 1.47B 118M 115M 5.06B | EV / Sales 2024 |
86,451,912x | EV / Sales 2025 | 78,013,766x |
| Free-Float |
92.52% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Provectus Biopharmaceuticals, Inc.
| 1 day | -1.83% | ||
| 1 week | -1.30% | ||
| Current month | -1.87% | ||
| 1 month | +12.38% | ||
| 3 months | +19.47% | ||
| 6 months | +10.19% | ||
| Current year | +21.82% |
| 1 week | 0.06 | 0.08 | |
| 1 month | 0.06 | 0.08 | |
| Current year | 0.04 | 0.08 | |
| 1 year | 0.04 | 0.1 | |
| 3 years | 0.04 | 0.22 | |
| 5 years | 0.03 | 0.22 | |
| 10 years | 0.01 | 0.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 16/04/2024 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 15/05/2012 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 25/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 03/04/2017 | |
John Lacey
BRD | Director/Board Member | 78 | 27/04/2018 |
Edward Pershing
CHM | Chairman | 73 | 27/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-30 | Free | Chairperson | 45,860 | 0.4858% | ||
| 06-30 | Free | Director | 48,917 | 0.5182% | ||
| 06-30 | Free | Director | 48,917 | 0.5182% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.83% | -1.30% | -10.98% | -45.52% | 28.6M | ||
| +1.84% | -0.66% | +59.82% | +94.48% | 54.88B | ||
| +0.29% | -5.81% | +57.12% | +130.18% | 54.63B | ||
| -2.24% | +3.59% | +17.75% | +469.23% | 25.06B | ||
| -1.60% | -6.21% | -18.96% | -16.06% | 23.14B | ||
| -1.74% | -1.27% | +39.51% | -8.30% | 19.87B | ||
| +0.16% | +2.49% | +36.52% | -27.60% | 17.55B | ||
| -6.84% | +2.18% | +195.12% | +364.56% | 16.5B | ||
| -1.74% | -3.06% | +48.05% | +640.88% | 15.75B | ||
| -1.05% | +1.16% | +25.95% | +191.69% | 14.2B | ||
| Average | -1.47% | -0.39% | +44.99% | +179.35% | 24.16B | |
| Weighted average by Cap. | -0.68% | -1.45% | +50.42% | +173.28% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.54 0.5 0.46 0.87 58.86 0.89 5.95 2.34 29 2.32 2.27 99.68 | 0.34 0.29 0.27 0.25 0.48 32.06 0.48 3.24 1.27 15.79 1.26 1.23 54.29 |
| Net income | -4.76M -4.17M -3.84M -3.55M -6.73M -454M -6.85M -45.91M -18.03M -224M -17.88M -17.49M -769M | -5.43M -4.75M -4.38M -4.05M -7.68M -518M -7.81M -52.35M -20.56M -255M -20.39M -19.95M -877M |
| Net Debt | 2.88M 2.52M 2.32M 2.14M 4.07M 274M 4.14M 27.74M 10.89M 135M 10.8M 10.57M 465M | 2.73M 2.39M 2.2M 2.03M 3.86M 260M 3.92M 26.29M 10.32M 128M 10.24M 10.02M 441M |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | US$0.0681 | -1.83% | 63,360 |
| 09/07/26 | US$0.0693 | -0.55% | 615,683 |
| 08/07/26 | US$0.0697 | +4.03% | 352,220 |
| 07/07/26 | US$0.0670 | -2.62% | 378,599 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions

















